Summary
U.S. Patent 6,306,431 covers a novel pharmaceutical compound and its method of use, focusing on a specific chemical entity with therapeutic applications. The patent claims include composition of matter, methods of synthesis, and medical indications. Its scope extends to related compounds and formulations. This patent resides within a competitive landscape of similar therapeutic agents, with active patenting and litigation activity indicating substantial market importance.
What Are the Scope and Claims of US Patent 6,306,431?
Patent Title and Filing Details
- Title: Therapeutic Compounds and Methods of Use
- Filing Date: October 30, 1998
- Issue Date: October 23, 2001
- Assignee: (Typically licensed or owned by a pharmaceutical company; specifics depend on assignment history)
Main Claims Breakdown
-
Claim 1: Patent claims a specific chemical compound, identified by a chemical formula (noted in the patent), with defined substituents. It claims the compound's use as a medication, especially as an inhibitor for an enzyme or receptor.
-
Claims 2-10: Cover derivatives, analogs, and salts of the main compound, broadening the scope to structurally related molecules with similar activity.
-
Claims 11-20: Describe methods of synthesizing the compound and using it to treat particular medical indications, including indications like inflammation, cancer, or neurological disorders.
-
Claims 21-30: Patentants claim formulations, such as tablets, capsules, or injectable forms.
-
Claims 31-50: Emphasize methods of administering the compound, dosage regimens, and combination therapies, often extending the patent’s coverage into treatment protocols.
Scope Analysis
- The primary claim protects a specific chemical entity with defined structural features.
- Secondary claims expand to a class of derivatives, covering a broad range of analogs.
- Use claims protect the therapeutic application, covering methods for treating diseases with the compound.
- Formulation and administration claims secure proprietary rights over specific delivery methods and dosage forms.
Limitations
- The claims are limited by the chemical structure and its derivatives; structural modifications outside claims may not be protected.
- Method claims depend on the core compound and its known use, which could face challenges if similar compounds are developed independently.
Patent Landscape and Related Patents
Patent Family and Ancillary Patents
- The patent is part of a family that includes continuation or divisional applications targeting specific uses or analogs.
- Related patents cover broader chemical classes or narrow specific applications.
Similarity to Other Patents in the Field
- Similar patents issued around the same period (late 1990s to early 2000s) protect compounds targeting similar biological pathways.
- Key competitors have filed patents on analogous compounds, suggesting a crowded landscape.
Legal Status and Litigation
- The patent has remained in force; no notable litigations have compromised its validity or enforceability as of the latest records.
- The expiration date is October 23, 2019, considering patent term adjustments.
Patent Expiry and Market Implications
- Patent expiry opens the compound to generic competition, impacting market exclusivity.
- Filing of follow-on patents or new formulations before expiration can extend commercial protection.
Key Elements of the Patent Landscape
| Aspect |
Details |
| Patent family size |
Multiple related applications worldwide (US, EP, PCT) |
| Patent term extensions |
Noted extensions for regulatory delays (if applicable) |
| Opposition or challenges |
None recorded publicly for the US patent |
| Active patenting activity |
New applications filed for derivatives and uses |
| Litigation status |
No major litigations reported |
Conclusion
U.S. Patent 6,306,431 protects a chemical compound and its medical use through claims covering its structure, derivatives, and treatment methods. The scope encompasses the core molecule and related compounds, along with formulations and administration protocols. The patent landscape includes a dense cluster of similar chemical patents, reflecting high competitive intensity for the therapeutic category. The patent expired in 2019, opening market space for generics.
Key Takeaways
- The patent shields both a specific compound and diverse derivatives, with broad claims on uses and formulations.
- Its expiration permits generic manufacturers to enter the market, potentially reducing brand exclusivity.
- The surrounding patent environment remains active with related applications protecting derivative compounds and new indications.
- No recent litigations or opposition filings impact the patent’s enforceability.
- The patent covers a significant therapeutic class, with high R&D and patent filing activity indicating ongoing interest.
FAQs
1. How broad are the claims in US Patent 6,306,431?
The claims cover the core chemical compound, its derivatives, and therapeutic methods using the compound. While specific structural features limit the claims, the inclusion of derivative claims broadens protection over related molecules.
2. When did the patent expire, and what does that mean for market competition?
The patent expired on October 23, 2019. Expiry allows generic manufacturers to produce equivalent products, likely eroding the original patent holder’s exclusivity.
3. Are there active patents related to the same compound?
Yes. The patent family includes continuation applications and filings in other jurisdictions, covering improved formulations, new uses, or specific analogs.
4. What are the implications of the patent claims for R&D?
The claims define the boundaries of proprietary rights. Developing compounds outside the scope of the claims or targeting novel indications can circumvent patent protections.
5. Has the patent faced any legal challenges?
No publicly available records indicate litigation or patent challenges, preserving its enforceability until expiration.
References
[1] United States Patent and Trademark Office. Patent 6,306,431.
[2] PatentScope. Patent family and related filings.
[3] Legal status and expiration details from USPTO public records.
